News

AbbVie has been globally committed for more than 25 years to the fight against HIV, including in South Africa.
 
Although a global increase in the demand for our antiretroviral therapy over the last year had resulted in temporary stock constraints, AbbVie took action to proactively address the unexpected constraints. In South Africa, AbbVie put into place a supply plan that both meets monthly demand expectations for patients and builds safety stock. The South African government has supported AbbVie’s plan, which is expected to meet patient need commitments in South Africa and ensure supply commitments with the government and other supply partners.
 
We continue to work closely with all partners to especially ensure that the needs of patients in rural or remote areas are well understood and immediately addressed with any further support the company can reasonably provide and so that patient therapy continues without interruption.